Natural History Study of Patients With Canavan Disease (CANinform Study)

Description

This study uses medical records that allow retrospective data extraction of critical milestone and motor function data. In addition, prospective assessments collect data relevant to the natural history of Canavan disease in children.

Conditions

Canavan Disease

Talk to us

Study Overview

On this page

Study Details

Study overview

This study uses medical records that allow retrospective data extraction of critical milestone and motor function data. In addition, prospective assessments collect data relevant to the natural history of Canavan disease in children.

A Combination Retrospective Medical History and Prospective Observational Study of Patients With Canavan Disease for Assessment of Natural History of Canavan Disease

Natural History Study of Patients With Canavan Disease (CANinform Study)

Condition
Canavan Disease
Intervention / Treatment

-

Contacts and Locations

Oakland

UCSF Benioff Children's Hospital Oakland, Oakland, California, United States, 94609

Boston

Massachusetts General Hospital, Boston, Massachusetts, United States, 02114

New York

NYU Langone Medical Center, New York, New York, United States, 10016

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Meet age criteria of a specific cohort.
  • 2. Confirmed clinical and biochemical diagnosis of Canavan disease.
  • 3. Available medical records since birth that permit documentation of disease characteristics and developmental milestones.
  • 4. Parent and/or legal guardian is able to read, understand, and sign the informed consent.
  • 1. Patient does not meet the Inclusion Criteria.

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Aspa Therapeutics,

Study Record Dates

2026-04-30